FREEHOLD, N.J., April 17, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (ALBT), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today announced the ...
Company Continues to Implement Major Change in Strategy Focused on Acquiring and Operating Accretive Revenue Generating Laboratories and Related Commercialized Products Company Plans on Developing and ...
New brokerage Avalon Commercial, founded by two veterans of commercial real estate, is focused on multifamily properties, such as the 250-unit Solara Apartments the firm brokered in a sale last month ...
FREEHOLD, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a commercial-stage company dedicated to developing and delivering precision ...